Physician profile
Sam Pourbabak
NPI 1043271018
$33,054.64
in general payments reported to CMS, 2019-2025
66 companies · $5,903 in 2025
The $5,903 reported for 2025 was more than what 88% of Endocrinology, Diabetes & Metabolism providers received nationally (typical 2025 total: $506).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,220 · 2020: $3,595 · 2021: $4,426 · 2022: $3,489 · 2023: $4,271 · 2024: $6,150 · 2025: $5,903.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,187 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $8,100 · Education: $37.26.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,187.15 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $8,100.00 |
| Education | $37.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $17,393.67 | 2019-2025 | |
| Lilly USA, LLC | $1,775.29 | 2019-2025 | Jardiance, Mounjaro, Trulicity |
| Novo Nordisk INC | $1,707.56 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Mannkind Corporation | $1,075.83 | 2019-2025 | Afrezza |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,019.91 | 2019-2025 | Jardiance, Synjardy |
| Astrazeneca Pharmaceuticals LP | $936.55 | 2019-2025 | Airsupra, Farxiga, Lokelma |
| Amgen INC. | $896.61 | 2019-2025 | Tepezza, Repatha, Evenity |
| Sanofi-Aventis U.S. LLC | $717.05 | 2019-2025 | |
| Abbott Laboratories | $676.08 | 2019-2025 | Freestyle Libre 3 |
| Insulet Corporation | $594.45 | 2019-2025 | Omnipod |
| Otsuka America Pharmaceutical, INC. | $594.26 | 2019-2025 | Jynarque |
| Corcept Therapeutics | $550.88 | 2019-2025 | Korlym |
| Amarin Pharma, INC. | $462.69 | 2019-2023 | |
| Antares Pharma, INC. | $404.60 | 2020-2025 | Xyosted |
| Bayer Healthcare Pharmaceuticals INC. | $378.55 | 2021-2024 |
Show all 66 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dexcom, INC. | $261.76 | 2019-2024 | Dexcom G6 Transmitter |
| Xeris Pharmaceuticals, INC. | $255.99 | 2022-2025 | Gvoke Hypopen, Recorlev |
| Averitas Pharma INC. | $215.76 | 2024-2025 | Qutenza |
| Kowa Pharmaceuticals America, INC. | $210.20 | 2019-2022 | |
| Calliditas Therapeutics US INC. | $204.97 | 2022-2025 | Tarpeyo |
| Merck Sharp & Dohme LLC | $202.81 | 2019-2023 | Steglatro, Belsomra |
| Mallinckrodt Hospital Products INC. | $199.73 | 2022-2025 | Acthar |
| Alexion Pharmaceuticals, INC. | $154.71 | 2019-2024 | Strensiq |
| Zealand Pharma US, INC. | $150.26 | 2020-2022 | |
| Esperion Therapeutics, INC. | $127.00 | 2022-2025 | Nexletol |
| Opko Pharmaceuticals, LLC | $117.07 | 2023-2024 | Rayaldee |
| Madrigal Pharmaceuticals | $109.06 | 2024-2025 | Rezdiffra, Resmetirom |
| Valeritas, INC. | $108.66 | 2019 | |
| Ibsa Pharma INC. | $107.56 | 2020-2023 | Tirosint, Licart |
| Embecta Corp. | $99.82 | 2023-2024 | Bd Nano 2nd Gen Pen Needle |
| Novartis Pharmaceuticals Corporation | $97.95 | 2022-2024 | |
| Cequr Corporation | $97.00 | 2022-2024 | Cequr Simplicity |
| Verity Pharmaceuticals INC. | $91.53 | 2024-2025 | Tlando |
| Horizon Therapeutics Plc | $86.89 | 2020-2023 | Tepezza |
| Currax Pharmaceuticals LLC | $83.40 | 2019-2025 | Contrave |
| Ascendis Pharma Endocrinology INC | $69.17 | 2025 | Yorvipath |
| Tolmar, INC. | $63.04 | 2024-2025 | Jatenzo |
| Recordati_rare_diseases_inc. | $59.09 | 2023-2024 | Isturisa, Signifor Lar |
| Acerus Pharmaceuticals Corporation | $58.34 | 2020 | |
| Alvogen INC | $44.49 | 2023 | Teriparatide |
| Ultragenyx Pharmaceutical INC. | $40.73 | 2020-2022 | |
| Kyowa Kirin, INC. | $37.98 | 2023-2025 | |
| Inari Medical, INC. | $37.61 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Travere Therapeutics, INC. | $35.17 | 2025 | |
| Astellas Pharma US INC | $30.06 | 2024 | Veozah |
| Ani Pharmaceuticals, INC. | $27.00 | 2025 | Purified Cortrophin Gel |
| Exact Sciences Corporation | $26.87 | 2024 | Cologuard Collection Kit |
| Chiesi USA, INC. | $26.35 | 2025 | Mycapssa |
| Radius Health, INC. | $25.06 | 2020 | |
| Daiichi Sankyo INC. | $23.45 | 2021 | |
| Exeltis, USA INC. | $23.17 | 2023 | Slynd |
| Takeda Pharmaceuticals U.S.A., INC. | $21.92 | 2021 | |
| Sequel Med Tech, LLC | $21.66 | 2025 | Twiist |
| Apellis Pharmaceuticals, INC. | $21.17 | 2025 | Empaveli |
| Aegerion Pharmaceuticals, INC. | $20.86 | 2019 | |
| Biohaven Pharmaceuticals, INC. | $18.80 | 2021 | |
| Glaxosmithkline, LLC. | $18.26 | 2019 | |
| Scilex Pharmaceuticals INC. | $17.41 | 2024 | |
| Beta Bionics, INC. | $16.93 | 2024 | Ilet Bionic Pancreas |
| Medtronic Minimed, INC. | $15.85 | 2019 | |
| Boston Scientific Corporation | $15.64 | 2023 | Wavewriter Alpha Prime 16 |
| Alfasigma USA, INC. | $15.58 | 2021 | |
| Allergan, INC. | $14.94 | 2020 | |
| Rhythm Pharmaceuticals, INC. | $14.67 | 2024 | Imcivree |
| Pfizer INC. | $13.71 | 2021 | |
| Nalpropion Pharmaceuticals LLC | $13.55 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sam Pourbabak listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.